DR. BRUCE T VOLPE, MD
Medical Practice at Mamaroneck Ave, White Plains, NY

License number
New York 00123789
Category
Medical Practice
Type
Neuromusculoskeletal Medicine & OMM
Address
Address 2
785 Mamaroneck Ave, White Plains, NY 10605
1 Sigma Pl, Bronx, NY 10471
Phone
(914) 597-2500
(914) 597-2439 (Fax)
(718) 543-4850

Personal information

See more information about BRUCE T VOLPE at radaris.com
Name
Address
Phone
Bruce Volpe
1 Sigma Pl, Bronx, NY 10471
Bruce Volpe
10 Sigma Pl, Bronx, NY 10471
Bruce Volpe
10 Sigma Pl, Bronx, NY 10471
Bruce Volpe
1 Sigma Pl, Bronx, NY 10471

Professional information

See more information about BRUCE T VOLPE at trustoria.com
Bruce T Volpe Photo 1
Dr. Bruce T Volpe, Manhasset NY - MD (Doctor of Medicine)

Dr. Bruce T Volpe, Manhasset NY - MD (Doctor of Medicine)

Specialties:
Internal Medicine, Neuropsychiatry (Neurology)
Address:
300 Community Dr, Manhasset 11030
(516) 562-3384 (Phone), (516) 562-2921 (Fax)
Burke Medical Group
785 Mamaroneck Ave, White Plains 10605
(914) 597-2332 (Phone)
Certifications:
Internal Medicine, 1976, Neurology, 1980
Awards:
Healthgrades Honor Roll
Languages:
English, Spanish
Hospitals:
300 Community Dr, Manhasset 11030
Burke Medical Group
785 Mamaroneck Ave, White Plains 10605
Hospital for Special Surgery
535 East 70Th St, New York 10021
Long Island Jewish Medical Center
270 76Th Ave, New Hyde Park 11040
Education:
Medical School
Yale University School Of Medicine
Graduated: 1973
University Of Chicago
Graduated: 1974
Colum Presby Hospital
Graduated: 1976
Cornell Ny Hospital
Graduated: 1975


Bruce Thomas Volpe Photo 2
Bruce Thomas Volpe, White Plains NY

Bruce Thomas Volpe, White Plains NY

Specialties:
Neurology, Internal Medicine, Neuromusculoskeletal Medicine & OMM
Work:
Burke Med Research Inst
785 Mamaroneck Ave, White Plains, NY 10605
Education:
Yale University (1973)


Bruce Volpe Photo 3
Treatment Of Cognitive Dysfunction In Lupus

Treatment Of Cognitive Dysfunction In Lupus

US Patent:
2007023, Oct 4, 2007
Filed:
Oct 5, 2004
Appl. No.:
10/574994
Inventors:
Betty Diamond - Bronx NY, US
Bruce Volpe - Bronx NY, US
International Classification:
A61K 38/08, A61K 38/10, A61K 38/16, A61K 39/395
US Classification:
424130100, 514012000, 514013000, 514014000, 514015000, 514016000, 514017000
Abstract:
Methods of preventing binding of an anti-double stranded (ds)-DNA antibody to a neuron in a mammal exhibiting or at risk for lupus-induced cognitive dysfunction are provided. Methods of inhibiting progression of cognitive dysfunction in a mammal exhibiting or at risk for lupus-induced cognitive dysfunction are also provided. Also provided are methods of inhibiting progression of cognitive dysfunction in a mammal exhibiting or at risk for lupus-induced cognitive dysfunction. Additionally, methods of inhibiting progression of cognitive dysfunction in a mammal exhibiting or at risk for lupus-induced cognitive dysfunction are provided. Further provided are methods of inducing cognitive dysfunction in a mammal, and nonhuman mammal treated with a DNA mimotope in such a manner to induce antibodies that bind to ds-DNA and an NR2 subunit of a neuron in the mammal, then, after the antibodies are induced, treated to temporarily open the blood brain barrier.


Bruce Volpe Photo 4
Testing Therapy Efficacy With Extremity And/Or Joint Attachments

Testing Therapy Efficacy With Extremity And/Or Joint Attachments

US Patent:
2006028, Dec 21, 2006
Filed:
Jun 16, 2005
Appl. No.:
11/154197
Inventors:
Neville Hogan - Sudbury MA, US
Hermano Krebs - Cambridge MA, US
Bruce Volpe - Bronx NY, US
Assignee:
Cornell Research Foundation, Inc. - Ithaca NY
Massachusetts Institute of Technology - Cambridge MA
International Classification:
A61B 5/117
US Classification:
600595000, 600587000
Abstract:
A method of measuring a change in neurological and/or muscular performance of a subject may include attaching an attachment to a subject. The subject may then be directed to perform a motion. A first force imposed by the subject on the attachment and/or a first motion of the attachment is sensed. The subject's first response may then be compared to a second response to determine a change in the subject's neurological and/or muscular performance.